PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 24069158-6 2013 In addition, TNF-alpha also stimulated c-Jun and ATF2 phosphorylation which were inhibited by pretreatment with SP600125 and SB202190, respectively, but not PD98059. pyrazolanthrone 112-120 activating transcription factor 2 Homo sapiens 49-53 24674138-10 2014 Furthermore, JNK inhibition with SP600125 reduced TGFbeta-induced ATF2 (but not Smad2) phosphorylation and CRP2 protein expression while ROCK inhibition blocked JNK activation. pyrazolanthrone 33-41 activating transcription factor 2 Homo sapiens 66-70 15721365-5 2005 Pre-treatment of NS3 protein-expressing cells with JNK inhibitor, SP600125, abolished activation of AP-1 and ATF-2 and inhibited c-jun expression and induced cell growth, suggesting that JNK activation is essential for the stimulation of NS3-mediated cell growth. pyrazolanthrone 66-74 activating transcription factor 2 Homo sapiens 109-114 17397142-7 2007 In contrast, the anthrapyrazolone compound, SP600125, exhibited competitive inhibition for ATP and noncompetitive inhibition against ATF2. pyrazolanthrone 44-52 activating transcription factor 2 Homo sapiens 133-137 16601071-7 2006 Use of the JNK inhibitor SP600125 or expression of dominant-negative JNK-activator SAPK kinase (SEK1) prevented the induction of ATF2-Thr69+71, but not ATF2-Thr71 phosphorylation by insulin. pyrazolanthrone 25-33 activating transcription factor 2 Homo sapiens 129-133 12898508-5 2003 Similarly, inhibition of JNK1 and JNK2 activities by the selective inhibitor SP600125 led to both dose-dependent reduction of c-jun and ATF-2 phosphorylation, and of the differentiation of HL60 cells. pyrazolanthrone 77-85 activating transcription factor 2 Homo sapiens 136-141 33806765-5 2021 The inhibition of hypoxia-activated phosphorylation of JNK signal components (JNK, MKK4, nuclear c-Jun and ATF-2) by pre-treatment with SP600125 could suppress hypoxia-stimulated HIF-1alpha upregulation and fibrotic marker proteins expression. pyrazolanthrone 136-144 activating transcription factor 2 Homo sapiens 107-112